Australian Super Pty LTD Nektar Therapeutics Transaction History

Australian Super Pty LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 13, 2020	SELL	$14.47 - $27.96 $6.5 Million - $12.6 Million	-449,470 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$15.87 - $23.12 $1.22 Million - $1.77 Million	76,575 Added 20.54%	449,470 $9.7 Million
Q3 2019 Nov 08, 2019	BUY	$16.91 - $36.27 $909,808 - $1.95 Million	53,803 Added 16.86%	372,895 $6.79 Million
Q2 2019 Aug 13, 2019	BUY	$31.0 - $36.3 $279,899 - $327,752	9,029 Added 2.91%	319,092 $11.4 Million
Q1 2019 May 14, 2019	BUY	$31.58 - $46.35 $8.13 Million - $11.9 Million	257,434 Added 489.15%	310,063 $10.4 Million

Q4 2018 Feb 06, 2019	BUY	$30.43 - $56.65 $1.6 Million - $2.98 Million	52,629 New	52,629 $1.73 Million

128

111M

150K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $231M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Australian Super Pty LTD, based on Form 13F filings with the SEC.

Stay updated on Australian Super Pty LTD with notifications on news.